Latest Articles
Grayscale Raised Historic $500M in First Quarter, Now It Holds 1.7% of Bitcoin Supply
By Darya Rudz
• 3 mins read
$160.1 million of the $503.7 million raised during the first quarter of 2020 is the inflow from new investors. According to Grayscale, the source of 88% of the funds came from hedge funds and other institutional investments.
Tesla (TSLA) Stock Up Nearly 2.5%, Musk to Face Shareholder Lawsuit over Going-Private Tweet
By Darya Rudz
• 3 mins read
Recently, Tesla got in hot water, as its founder Elon Musk seems to have misled shareholders. Regulators considered his tweet about going private an attempt to defraud shareholders and manipulate Tesla (TSLA) stock price.
Alphabet (GOOGL) Stock Lost 0.63% Yesterday, CEO Told Employees Company Will Slow Hiring
By Darya Rudz
• 3 mins read
Alphabet (GOOGL) stock plunged yesterday as the company decided to slow down hiring new employees for the rest of this year and reduce spending in such areas as data centers.
JNJ Stock Up 1%, Jim Cramer Says Johnson & Johnson Is Ahead of COVID-19 Vaccine Game
By Darya Rudz
• 3 mins read
According to Jim Cramer, Johnson & Johnson COVID-19 vaccine candidate will help the public overcome fears of going out and spending money on entertainment. Meanwhile, JNJ stock went 1% up yesterday.
Goldman Sachs Earnings Partially Beat Expectations, GS Stock Doesn’t React, Down Less 1%
By Darya Rudz
• 3 mins read
Leading banks’ earnings have both beat and missed analysts’ expectations. Goldman Sachs, Citigroup, and Bank of America stocks are all down now.
TSLA Stock Rises 5.16% in Pre-Market, Tesla’s China Car Registrations Surge in March
By Darya Rudz
• 3 mins read
The number of Tesla car registrations in China rose 450% in March to reach 12,709 units. Some analysts believe backsliding is unlikely to take place in the upcoming days. Now TSLA stock is rising.
Pharma Giants Sanofi and GlaxoSmithKline Join Hands to Develop Coronavirus Vaccine
By Darya Rudz
• 3 mins read
Within the partnership, Sanofi will contribute its S-protein COVID-19 antigen based on recombinant DNA technology, while GlaxoSmithKline will implement its proven pandemic adjuvant technology.
Wells Fargo (WFC) Stock Plunges Over 4% after Bank Delivers Q1 2020 Earnings Report
By Darya Rudz
• 3 mins read
Wells Fargo’s net income made up $653 million. Its diluted earnings per share (EPS) is just $0.01, while analysts predicted earnings of $0.33 per share. Wells Fargo also failed to surpass the $12.3 billion net interest income in the year-earlier period. This time, it totaled $11.3 billion.
PayPal, Intuit and Square Offer Loans to Small Businesses as Part of Coronavirus Relief Program
By Darya Rudz
• 4 mins read
PayPal, Intuit and Square got approved to take part in the coronavirus relief program and offer loans to small businesses. Meanwhile, PayPal, and Square stocks closed in the green on April 13, 0.13% and 0.35% up correspondingly. Intuit shares slightly tanked.
WHO: 70 COVID-19 Vaccines in Progress, U.S. Moderna and Inovio Are Among Leaders
By Darya Rudz
• 3 mins read
Three of the COVID-19 vaccine developers have already entered the stage of human trials. These are CanSino, Inovio Pharmaceuticals, and Moderna. Other 67 potential COVID-19 vaccines are still in preclinical evaluation.